Lumateperone for acute exacerbations of psychosis in schizophrenia

featured image
Indications: Schizophrenia
Therapeutic Areas: Mental and Behavioural Health
Year: 2017

Lumateperone is a new, orally administered antipsychotic drug which alters levels of several chemicals in the brain including dopamine, serotonin and glutamate. Studies on lumateperone in people with schizophrenia experiencing an episode of severe symptoms suggest it may reduce symptoms with less side effects than current antipsychotic medication.If licensed lumateperone may provide an alternative treatment option for people with schizophrenia which may cause fewer side effects.